A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.
- 1 March 1992
- journal article
- Vol. 11 (3) , 1015-23
Abstract
Inhibition of gene transcription is brought about by several mechanisms. The least understood mechanism is probably silencing, the analogue to transcriptional enhancing. We provide evidence that the silencing function of the oncogene product v-ERBA or the cellular counterpart, the thyroid hormone receptor (TR, c-erbA) is located in the C-terminal part and is transferable to a heterologous DNA binding domain. Deletion analyses suggest an important role for a basic and hydrophilic amino acid stretch on both ends of the domain. In addition we show that the related retinoic acid receptor (RAR) also contains a functional silencing domain similar in size and amino acid sequence. However, the activity of this domain can be neutralized by an additional domain in the C-terminus which functions cell specifically.This publication has 43 references indexed in Scilit:
- Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptorsCell, 1991
- Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expressionCell, 1990
- v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbACell, 1990
- Transcriptional repression in eukaryotesTrends in Genetics, 1990
- An amino-terminal fragment of GAL4 binds DNA as a dimerJournal of Molecular Biology, 1989
- Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene productNature, 1989
- Nuclear receptors enhance our understanding of transcription regulationTrends in Genetics, 1988
- Developmental regulation of β-globin gene switchingCell, 1988
- How eukaryotic transcriptional activators workNature, 1988
- Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformationCell, 1983